Thompson W R, Alexander H R, Martin A J, Fletcher J R, Ghosh B C
J Surg Oncol. 1985 Jul;29(3):184-6. doi: 10.1002/jso.2930290311.
Recent experience with 108 Broviac catheters was reviewed. Sixty-eight were percutaneously placed in the subclavian veins of adults receiving systemic chemotherapy. For subclavian catheters perioperative and late complications were unusual. There was no pneumothorax or serious bleeding associated with insertion, even in severely thrombocytopenic patients. Mean catheter life was 93 days. Infection occurred in only five cases (7%). We conclude that percutaneous placement of right atrial catheters is a safe procedure which provides reliable access for prolonged chemotherapy in cancer patients.
回顾了108根Broviac导管的近期使用经验。68根经皮置入接受全身化疗的成年患者的锁骨下静脉。对于锁骨下导管，围手术期和晚期并发症并不常见。即使在严重血小板减少的患者中，插入导管时也没有发生气胸或严重出血。导管平均使用时间为93天。仅5例（7%）发生感染。我们得出结论，经皮置入右心房导管是一种安全的操作，可为癌症患者长期化疗提供可靠的通路。
